TRIPLE POSITIVE GROUP

1100910101012101410151334

Comments

  • ang7894
    ang7894 Member Posts: 540
    edited March 2017

    Ok little late on response here !! Sorry been gone for a while. I just had to write in on the period issue I have not had a period since my first chemo back in Jan 2012 At the time of first chemo I was almost 44 years old Nothing not even light , Then Bam !!! 5 years later yes I said 5 years later at 49 years old, I just had bleeding from HELL !!! So much so I had to use 2 pads at once and it was still making me go through my pants I bleed for 5 Days like this !! SORRY to much info I know !! I am not on tamox or anything else. I quit tamox after taking it for 2 1/2 years. out of the 5 years. SO I know omg I freaked out and right away I go in to my Obgyn he does all kinds of test in office like right away and the next day gave me 2 different ultra sounds, belly then vaginal. 2 times of blood work then a D&C At the hospital days later.. Get this all this and they can't find anything wrong !!! great news :) BUT he said it's real rare to just out of the blue to have a period after 5 years !! Even blood work showed Post menopausal So he is just as stumped. I told him I guess I will think that my body wanted to say No your not done and gave me one more before the good bye. Who knows But it sure was pretty scary .

  • shelabela
    shelabela Member Posts: 584
    edited March 2017

    I had my 7th treatment yesterday of Taxol and 3rd with Herceptin and Prejeta. This morning I am so shaky. Of course I always am the next morning.

    My MO meet with me yesterday before chemo and she did a physical. She does not think the lump is getting smaller. So she ushered me to the ultrasound room. Nope it measures the same size as it was before I started. On the good side it is not getting bigger.

    She told me that my side effects would get worse in the next couple weeks. Why? I guess I was a little upset after the ultrasound to ask that. So I ask here first. Why will they get worse? Is it the more treatments you have they cumulatively build up?

    Hoping I keep feeling good.

    Sending positive vibes to everyone else who has treatment today or yesterday

  • danix5
    danix5 Member Posts: 755
    edited March 2017

    I am confused about this newer categorizing of breast cancer. From Mayo-

    "Doctors are increasingly using genetic information about breast cancer cells to categorize breast cancers. These groups help guide decisions about which treatments are best. Breast cancer groups include:

    Group 1 (luminal A). This group includes tumors that are ER positive and PR positive, but negative for HER2. Luminal A breast cancers are likely to benefit from hormone therapy and may also benefit from chemotherapy.

    Group 2 (luminal B). This type includes tumors that are ER positive, PR negative and HER2 positive. Luminal B breast cancers are likely to benefit from chemotherapy and may benefit from hormone therapy and treatment targeted to HER2.

    Group 3 (HER2 positive). This type includes tumors that are ER negative and PR negative, but HER2 positive. HER2 breast cancers are likely to benefit from chemotherapy and treatment targeted to HER2.

    Group 4 (basal-like). This type, which is also called triple-negative breast cancer, includes tumors that are ER negative, PR negative and HER2 negative. Basal-like breast cancers are likely to benefit from chemotherapy."

    I AM TRIPLE POSITIVE, ER 98.80%, ER 77.77% HER2+++, plus Ki-67 15%

    So I don't fall in any of these 4 luminal subcategories. Is there a mix category?

    BTW my stats above are AFTER my first round with BC in 2007, re diagnosed this year. So 2007 bilateral mastectomy and hyster/ oopher and still thus crazy high grade HER2+ and high % for both ER/PR EVEN WITH NO OVARIES FOR OVER 9 years! Adrenal glands production will be turned off soon on one of the AI's for post menopausal not sure which one yet!

    I would like to ask this group which seems to have the least side effects?

  • SpecialK
    SpecialK Member Posts: 16,486
    edited March 2017

    dani - these are the molecular subtypes of breast cancer, but the descriptions you included are less than fully expanded. Here is a better listing from this site, which indicates that someone who is triple positive would be Luminal B. If you measure at a treatable level of Her2, generally your Ki% is also high, as is your grade. It is a pretty reliable and common marker of the aggressiveness of Her2+ breast cancer. Also, your ER% percentage has no connection to your hormonal levels, but is measuring the number of receptors on the breast cancer cells. It is a measure of how available those cells are to any amount of estrogen your body may produce. I also had a 96% ER+ BC nine years after a complete hyst/ooph. As far as the AI with the least side effects, that can be tied to which works for you as an individual - I don't think there is much consensus on that, but finding the manufacturer with the least fillers and additives seems to be helpful. My MO feels that Femara (or generic letrozole) has a slight performance edge, and I take the Roxane generic brand, which is pretty clean. I have taken a variety of different brands and that is the one I have been able to stay on the longest (I have also taken Mylan, and Teva brands, and the Accord brand of Arimidex over the six years I have taken anti-hormonals) and I am still on it now.


    There are five main intrinsic or molecular subtypes of breast cancer that are based on the genes a cancer expresses:

    • Luminal A breast cancer is hormone-receptor positive (estrogen-receptor and/or progesterone-receptor positive), HER2 negative, and has low levels of the protein Ki-67, which helps control how fast cancer cells grow. Luminal A cancers are low-grade, tend to grow slowly and have the best prognosis.
    • Luminal B breast cancer is hormone-receptor positive (estrogen-receptor and/or progesterone-receptor positive), and either HER2 positive or HER2 negative with high levels of Ki-67. Luminal B cancers generally grow slightly faster than luminal A cancers and their prognosis is slightly worse.
    • Triple-negative/basal-like breast cancer is hormone-receptor negative (estrogen-receptor and progesterone-receptor negative) and HER2 negative. This type of cancer is more common in women with BRCA1 gene mutations. Researchers aren't sure why, but this type of cancer also is more common among younger and African-American women.
    • HER2-enriched breast cancer is hormone-receptor negative (estrogen-receptor and progesterone-receptor negative) and HER2 positive. HER2-enriched cancers tend to grow faster than luminal cancers and can have a worse prognosis, but they are often successfully treated with targeted therapies aimed at the HER2 protein, such as Herceptin (chemical name: trastuzumab), Perjeta (chemical name: pertuzumab), Tykerb (chemical name: lapatinib), and Kadcyla (chemical name: T-DM1 or ado-trastuzumab emtansine).
    • Normal-like breast cancer is similar to luminal A disease: hormone-receptor positive (estrogen-receptor and/or progesterone-receptor positive), HER2 negative, and has low levels of the protein Ki-67, which helps control how fast cancer cells grow. Still, while normal-like breast cancer has a good prognosis, its prognosis is slightly worse than luminal A cancer's prognosis.
  • coachvicky
    coachvicky Member Posts: 1,057
    edited March 2017

    SpecialK

    What does slightly worse mean in the Luminal B description?

    Coach Vicky

  • SpecialK
    SpecialK Member Posts: 16,486
    edited March 2017

    coachvicky - I wouldn't read into it too much other than a Luminal B cancer is more likely to need systemic treatment either due to the Her2+ status or a higher Oncotype Dx or other genetic assay score than some Luminal A patients, and thus be considered to have a poorer prognosis. Tumor size and nodal status certainly can be factors in survival regardless of molecular subtype, so broad statements about survivability based on subtype don't apply to us as individuals, but generally more aggressive cancers have a poorer prognosis.

  • coachvicky
    coachvicky Member Posts: 1,057
    edited March 2017

    Thank you,SpecialK!

    Coach Vick

  • Robin1234
    Robin1234 Member Posts: 45
    edited March 2017

    just had my port put in yesterday and today I I noticed my veins and my neck or enlarged called the doctor she told me put warm compresses on it and take some ibuprofen that its inflammation. Has anyone else had this problem after port surgery? Worried

  • Moderators
    Moderators Member Posts: 25,912
    edited March 2017

    Hi all -- some news you might be interested in:

    Diabetes Medicine Linked to Better Outcomes in Diabetics With HER2-Positive, Hormone-Receptor-Positive Breast Cancer
    March 16, 2017

    Diabetic women treated with metformin who have been diagnosed with HER2-positive, hormone-receptor-positive breast cancer have better outcomes, including overall survival, than similar women who were not treated with metformin. Read more...

  • LizA17
    LizA17 Member Posts: 159
    edited March 2017

    Why do they give you a time line on the Arimidex after all treatment. I read where some are asking to be taken off before 5 yrs and Dr's tell them no. Also, why do some Dr's think 5 yrs and others 10 yrs?

  • SpecialK
    SpecialK Member Posts: 16,486
    edited March 2017

    Liz - five years was the standard amount of time for both Tamoxifen and aromatase inhibitors, based on previous studies. There was some thought that both drugs provided some carryover protection beyond the five year period versus not having taken anti-hormonal therapy at all. With Tamoxifen initially, a study was conducted lengthening the therapy time to 10 years, which showed improved DFS and OS. Here is a link:

    http://www.breastcancer.org/research-news/20130604

    Later studies were done on aromatase inhibitors in the same fashion, link:

    http://www.breastcancer.org/research-news/10-yrs-of-femara-better-than-5

    Doctors have differing opinions regarding benefit based on their experience and how current they are keeping on studies - and how much credence they place in those studies. The BCI test (Biotheranostics) - a genetic assay done on the patient's original tumor, indicates whether one is at risk of recurrence beyond five years, and whether or not , based on the assay results, you will benefit from continuing anti-hormonal therapy. It is a fairly small number of patients who have quantifiable benefit from continuing AI therapy, which comes with side effects that can affect quality of life. In spite of this there are some docs who are asking their patients to continue with anti-hormonals for 10 years without testing of any kind - this may be their blanket approach, or they may be considering each patient clinically before making that recommendation. Link:

    https://www.answersbeyond5.com/what-is-bci

    I had a BCI test done and the result indicated that I was high risk for recurrence, but received little benefit from AI therapy. To me, that meant I had received little benefit for the five years I had already been taking it so I asked for a PET/CT, since it had been a few years since I had one. My oncologist has asked me to continue Femara as long as I can handle the side effects, because even though I seem to receive little benefit, it is not necessarily zero benefit.

  • wabals
    wabals Member Posts: 242
    edited March 2017

    SpecialK

    I am triple pos with KI67 of 10. Never made sense to me

  • SpecialK
    SpecialK Member Posts: 16,486
    edited March 2017

    wabals - I understand, - I had a massive Ki67 percentage and a mitotic rate of 1 - discordant for sure. The other two components of my grade were pegged, I am thinking the slide the pathologist looked at was from an indolent section of the biopsy sample. My surgical tissue sample was not re-graded or tested for receptors or Her2 status, but that may be because in addition to it being done in pathology for the biopsy cores I also had Mammaprint done. Side note: If you live in Leesburg, I spent a lot of time at the equine hospital at Morven Park - we used to take care of the neonate foals in the spring, lived in Springfield for 10 years, DH was stationed at the Pentagon. My son is a firefighter/paramedic in Loudon County now - small world, right?

  • deni1661
    deni1661 Member Posts: 463
    edited March 2017

    Robin 1234 -I had swelling after my port surgery. It took a week or so for things to get back to normal. My vein is still noticeable when I turn a certain way. Keep an eye on it though, it shouldn't get worse. Take care



  • wabals
    wabals Member Posts: 242
    edited March 2017

    Small world indeed! We also live in Fl. On Hutchinson Island and went to Tampa when we were evacuated. If you have plans to come to Va message me. Would love to meet you! Are youan NP? I was until I retired.

    My path was done on my tumor after surgery. My mitotic rate was also low. Go figure

  • wabals
    wabals Member Posts: 242
    edited March 2017

    Special K OMG my grandson is a firefighter in training now in Loudoun! He was a cadet and a volunteer for 4 years. Now making it his career. So proud. My granddaughter was an EMT volunteer in purcellville score she got married

  • SpecialK
    SpecialK Member Posts: 16,486
    edited March 2017

    wabals - I was coming to Virginia regularly from 2012-2015, and stayed with my son in Sterling several times, for a Her2+ vaccine trial through Johns Hopkins at Sibley in D.C. I am done with the active phase of the trial - now am just being followed on the phone. My son moved to Great Falls, but still volunteers at the fire station in Ashburn. Where did your grandson volunteer? How funny if they know each other! My last trip up to the area was last summer, unfortunately for a funeral for an old military friend who had stage IV BC. I have many friends still up there and need to come back up to see everyone! I will def let you know if I am headed up that way - would love to meet you too! I was fortunate to meet several from BCO during my trips north for the trial, and also to meet other trial participants who were Her2+. I am not an NP, worked here in Tampa in Transfusion Services administratively, in the same hospital my BMX was done in, but left there in 2011 - too much treatment that still needed to be done and upcoming surgery - it wasn't fair to my colleagues, so I resigned. I have a re-hire clause so I could return but not feeling that working in a hospital is where I want to be, have been a patient too many times now, lol!

  • PoseyGirl
    PoseyGirl Member Posts: 359
    edited March 2017

    Hi Ladies,

    I'm having an oophorectomy (I'm 48, so close to menopause anyhow) on Monday and will then be switched to an AI versus the Tamoxifen I started a few months ago. I'm wondering SpecialK how you knew that you received little benefit from the AI?

    Another Q unrelated...does anyone know on this thread why PCR after chemo doesn't necessarily make a huge positive difference for triple positive patients in terms of recurrence? I am IIIA and didn't have any cancer in my breast or nodes after chemo. But when I read about complete response, several large studies have indicated that for triple negative and Her2+, there certainly is a massive association between pCR and recurrence. But with triple positive, while it's a bit of a positive association, it's not huge like those two (and hormone positive only receptor cancer doesn't show any predictive value...but in this case, I think that's because recurrence with hormone positive BC's recur mostly after 10 years and studies rarely go past 8 years).

    Finally, while I'm triple positive, I kind of wonder if I'm more 'double positive'. I'm 90% estrogen positive, just 5% progesterone positive, and of course HER2+.

    Thoughts?

  • wabals
    wabals Member Posts: 242
    edited March 2017

    Special KAnother thing in common. I am in the ATEMPT trial and got most of my treatments at Sibley.

    Finished all treatment except arimidex. Message me with your son's name

  • SpecialK
    SpecialK Member Posts: 16,486
    edited March 2017

    posey - I too have a lower % of PR than ER. There is some school of thought that having lower PR percentages might make for a more aggressive cancer, and less effective anti-hormonal efficacy. At the 5-year point of taking aromatase inhibitors I had the BCI test done. It is both prognostic and predictive and shows two results, recurrence risk beyond 5 years, and benefit of the meds beyond five years - these results are based on the genetic info derived from the original tumor. My theory is that if testing the original tumor showed limited benefit going beyond five years, it also showed limited benefit for the five years I had already been taking Femara.

    wabals - Pmed you.

  • PoseyGirl
    PoseyGirl Member Posts: 359
    edited March 2017

    Do you get offered these tests in the US or do you have to research to find out about them and then pay? As a person receiving treatment in Ontario, Canada, I really feel we are offered so much less by way of genetic testing etc. Just wondering if you have to push for it or if it's presented up front as a good course of action to take.

    I have read about the presence of PR versus lack of presence and I believe there is evidence that it's better to have the PR, yes. It doesn't seem like a drastic difference, but definitely has an effect it seems.

  • coachvicky
    coachvicky Member Posts: 1,057
    edited March 2017

    Robin1234,

    The vein in my neck sticks out and has since my port was inserted in August 2016. I think it is because I am thin.

    The initial pain fads. The port is really wonderful and makes chemo much easier. I still hate mine. I just don't like it in my body.

    Coach Vicky

  • Nothappy
    Nothappy Member Posts: 11
    edited March 2017

    How often did you have pet scans?

  • Tresjoli2
    Tresjoli2 Member Posts: 868
    edited March 2017

    I never got my ki score or my mitotic rate. Sample was too small I think...

  • SpecialK
    SpecialK Member Posts: 16,486
    edited March 2017

    posey - the BCI test was offered by my MO without any prompting from me, although I was aware of the existence of the test.

  • shelabela
    shelabela Member Posts: 584
    edited March 2017

    I was offered the test also. Depending on circumstances for insurance coverage though. Mine did cover it because of my age and no family history

  • SpecialK
    SpecialK Member Posts: 16,486
    edited March 2017

    My insurance did not cover it, but because I am insured and insurance denied, Biotheranostics takes over the appeal process. If they are unsuccessful, they do not charge the patient anything.

  • Suburbs
    Suburbs Member Posts: 429
    edited March 2017

    Hi everyone. The discussion of testing leads me to three questions about surgery. 1. ) What testing and pathology should you expect or want to see after surgery? I have read about genomic assays and various tests with some being specifically mentioned as not appropriate for HER2 + patients. Sounds like a mixed bag in terms of what is typically ordered or not. The pathology report for my second biopsy did not include testing for HER2 status. This annoyed me.

    2.) After neoadjuvant, but before surgery, what testing should one insist upon. Having no MRI after neoadjuvant but before mastectomy because you are "getting a mastectomy anyway". This annoys me. Going through seven months of anxiety and 4 months of chemo fun and having no measure of efficacy until a week after surgery in the form of pathology annoys me.

    3.) When a "healthy" breast is removed in connection with a BMX, no pathology is conducted. Has anyone been in this situation. Given years of failure to diagnose properly the 10 cm field of unhealthy tissue in my right, it seems like the left should at least get a look under a microscope. If it were determined to be cancerous, the lymph nodes would need to be assessed.

    Thanks in advance for sharing your experiences.
  • PoseyGirl
    PoseyGirl Member Posts: 359
    edited March 2017

    Sorry if my message shows up twice...I was typing and the screen just refreshed!

    In terms of genetic testing, I do think that it's kind of random as to what you get offered (and when I say that, I mean beyond the obvious reasons to get genetic testing such as young age and possible gene mutations, etc.). I personally think it depends on your MO's personal approach and where you live, etc.

    As for scan testing, again I think it depends on each situation. Two years before my diagnosis, they found microcalcifications in my breast (that side was always very fibrocystic - more so than the left). They did a biopsy and that turned up negative. Then, a year before diagnosis, I had a mammo done. I'm positive my cancer was there at the time, but the mammo totally missed it due to my extreme breast density. So throughout my chemo treatments, they did about 4 ultrasound scans (or 3? Can't remember). I had one about a month before surgery and it wasn't showing any change from about 2 months prior. This was pretty upsetting. But then they did surgery and the path report showed complete response in the nodes and breast. This showed me that the tests can miss things depending on your breast density. They told me that my breast was very difficult to monitor across all modalities. My MO did tell me all the way along that pathology was the definitive statement. It is frustrating and scary for sure. I had to lie down in my oncologist's office as I felt I was going to pass out when she told me yet again there wasn't much change.

    So, I guess what I'm saying is that a) you should push for tests if you want them, and b) the tests aren't King always (ultrasound and mammo and MRI). As for your healthy breast...I'm in the same situation wondering about that. I've asked them to do another ultrasound on my left to keep watch. I am thinking I might one day just have it off (because I've learned that the tests aren't 100% for me given density).


  • PoseyGirl
    PoseyGirl Member Posts: 359
    edited March 2017

    Thanks for your feedback, Special K!

Categories